Market Tracker

02/23 5:15pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.40
Delayed Data
As of Feb 23
 +0.03 / +0.41%
Today’s Change
5.85
Today|||52-Week Range
11.34
-17.78%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close7.37
Today’s open7.36
Day’s range7.36 - 7.45
Volume18,850
Average volume (3 months)38,917
Market cap$106.3M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+9.20%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+283.15%
P/E ratioNM
Price/Sales46.88
Price/Book5.26

Competitors

 Today’s
change
Today’s
% change
AGRXAgile Therapeutics I...-0.02-0.54%
MTNBMatinas BioPharma Ho...+0.02+1.98%
--EcoGreen Internation...+0.00+1.42%
CPIXCumberland Pharmaceu...-0.13-1.90%
Data as of 8:00pm ET, 02/23/2018

Financials

Next reporting dateApril 5, 2018
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$2.5M
Annual profit (last year)-$10.5M
Net profit margin-426.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts